2023 San Diego Hematology Oncology Conference

San Diego, CA US
July 22, 2023 to July 23, 2023

This CME-accredited oncology conference, 2023 San Diego Hematology Oncology Conference, is designed to improve the care of cancer patients by educating clinicians involved in cancer care.  

Expert faculty will provide a comprehensive overview of practice-changing abstracts presented at the 2023 ASCO® Annual Meeting (ASCO2023) in June 2023. The program includes in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field. Expert faculty will place abstract findings from ASCO2023 into clinical contexts and discuss how the results may change the current standard of care.

 

SILVER SPONSOR

Target Audience

  • Medical oncologists
  • Hematologist oncologists
  • Radiation oncologists
  • Surgical oncologists
  • Oncology residents/fellows
  • Oncology NPs/PAs
  • Oncology pharmacists
  • Oncology nurses

Hotel information

Hyatt Regency Mission Bay

Learning Objectives

  1. Discuss new and updated treatment options for patients with hematologic malignancies and solid tumors
  2. Identify side effects, indications, and contra-indications of therapies used to diagnose and treat cancers
  3. Explain how to effectively manage side-effects associated with cancer treatment
  4. Review abstracts presented at ASCO® 2023 and discuss their application in clinical settings
Course summary
Available credit: 
  • 11.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 11.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 11.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 11.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 11.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 11.00 Contact Hours.
Course opens: 
03/10/2023
Course expires: 
10/22/2023
Event starts: 
07/22/2023 - 8:00am PDT
Event ends: 
07/23/2023 - 12:15pm PDT
Cost:
$350.00

Conference Co-Chairs: Drs. Sandip Patel and Daneng Li

DAY 1 – July 22, 2023

All times are listed in Pacific Time (PT)

07:00 – 08:00 AM: REGISTRATION, BREAKFAST, EXHIBITS


08:00 – 08:05 AM: Welcome - Sandip Patel, MD and Daneng Li, MD

08:05 – 08:15 AM: Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD


08:15 – 09:45 AM: SESSION 1 - HEMATOLOGIC MALIGNANCIES SESSION

08:15 – 08:45 AM: MDS/Leukemias - James K. Mangan, MD, PhD

08:45 – 09:15 AM: Multiple Myeloma - Autumn Jeong, MD

09:15 – 09:45 AM: Lymphoma & CLL - Michael Choi, MD


09:45 – 10:00 AM: BREAK AND EXHIBITS


10:00 – 11:00 AM: SESSION 2 - THORACIC ONCOLOGY SESSION

10:00 – 10:30 AM: Early-Stage Lung Cancer - Kathryn Gold, MD

10:30 – 11:00 AM: Metastatic Lung Cancer - Aditya Sarvaria, MD


11:00 AM – 12:00 PM: SESSION 3 - CASE-BASED PRESENTATIONS

Speakers: Catherine Quinn, MD; Dong Xiang, MD; Xuan Ge, MD, PhD; Andy (Sew-Chung) Jang, MD; Jeffrey Velotta, MD


12:00 – 01:00 PM: LUNCH AND EXHIBITS


01:00 – 03:00 PM: SESSION 4 - GENERAL ONCOLOGY SESSION

01:00 – 01:30 PM: Sarcoma Updates - Janet Yoon, MD

01:30 – 02:00 PM: Brain Tumor Updates - Jana Portnow, MD

02:00 – 02:30 PM: Head Neck Cancer - Victoria Villaflor, MD

02:30 – 03:00 PM: Gynecologic Cancer - Pratibha Binder, MD


03:00 – 03:30 PM: BREAK AND EXHIBITS


03:30 – 05:00 PM: SESSION 5 - GENITOURINARY CANCER SESSION

03:30 – 04:00 PM: Prostate Cancer - Tanya Dorff, MD

04:00 – 04:30 PM: Bladder Cancer - Abhishek Tripathi, MD

04:30 – 05:00 PM: Kidney Cancer - Rana Mckay, MD


DAY 2 – July 23, 2023

07:00 – 08:00 AM: REGISTRATION, BREAKFAST, EXHIBITS


08:00 – 08:30 AM: SESSION 6 - SKIN CANCER

08:00 – 08:30 AM: Melanoma Update - Gregory Daniels, MD, PhD


08:30 – 09:00 AM: SESSION 7 - CASE-BASED PRESENTATIONS

Speakers: Hardeep Phull, MD; Soo Park, MD; Wei Bai, MD


09:00 – 10:30 AM: SESSION 8 - GI CANCER SESSION

09:00  09:30 AM: Colorectal Cancer - Marwan Fakih, MD

09:30 – 10:00 AM: Hepatobiliary and Pancreatic Malignancies - Vincent Chung, MD

10:00 – 10:30 AM: Upper GI Cancer - Syma Iqbal, MD


10:30 – 10:45 AM: BREAK AND EXHIBITS


10:45 AM – 12:15 PM: SESSION 9 - BREAST CANCER SESSION

10:45 – 11:15 AM: HER2 Positive - Sayeh Lavasani, MD

11:15 – 11:45 AM: Hormone Receptor Positive - Kay Yeung, MD, PhD

11:45 AM – 12:15 PM: Triple Negative Breast Cancer - Yuan Yuan, MD, PhD


12:15 PM: ADJOURN

Hyatt Regency Mission Bay
1441 Quivira Rd
San Diego, CA 92109
United States

Hotel room reservation

A limited number of guestrooms are reserved at the Hyatt Regency Mission bay for the participants of this meeting at a discounted rate of $389 per night. The room rate doesn't include the discounted resort fee of $20/night and any applicable taxes.

CUTOFF - Wednesday, June 21, 2023

Please use the link below to reserve your room for the discounted rate. The rate is good through Wednesday, June 21, 2023.

https://www.hyatt.com/en-US/group-booking/SANIS/G-BINY

Reservation Cancellation:

Please cancel your room reservation 72 hours before arrival date to avoid being charged for one night.

Parking:

The hotel is offering a discounted event parking of $10/day for self-parking and $15/day for Valet parking. The overnight parking is discounted to $35/night.

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

 

Course Director(s)

Daneng Li

has a financial relationship (Independent contractor) with Adagene;.
has a financial relationship (Independent contractor) with Ipsen;.
has a financial relationship (Independent contractor) with Coherus;.
has a financial relationship (Grant Or Contract) with Brooklyn ImmunoTherapeutics;.
has a financial relationship (Independent contractor) with Genentech;.
has a financial relationship (Independent contractor) with Servier;.
has a financial relationship (Grant Or Contract) with AstraZeneca;.
has a financial relationship (Independent contractor) with Exelixis;.
has a financial relationship (Independent contractor) with QED;.
has a financial relationship (Independent contractor) with Eisai;.
has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Independent contractor) with TerSera Therapeutics;.

Sandip Patel, MD

has a financial relationship (Grant Or Contract) with BMS;.
has a financial relationship (Grant Or Contract) with Pfizer;.
has a financial relationship (Grant Or Contract) with AstraZeneca/MedImmune;.
has a financial relationship (Grant Or Contract) with Roche/Genentech;.
has a financial relationship (Grant Or Contract) with Merck;.
has a financial relationship (Grant Or Contract) with Novartis;.

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.
Speaker/Topic Presenter(s)

Wei Bai, MD

has no relevant financial relationships to disclose at this time.

Pratibha Binder, MD, MSCI

has no relevant financial relationships to disclose at this time.

Michael Choi, MD

has no relevant financial relationships to disclose at this time.

Vincent Chung, MD

has a financial relationship (Grant Or Contract) with Merck;.
has a financial relationship (Professional Services) with Perthera;.

Gregory Daniels, MD PhD

has no relevant financial relationships to disclose at this time.

Tanya Dorff, MD

has a financial relationship (Professional Services) with AstraZeneca;.
has a financial relationship (Professional Services) with Astellas;.
has a financial relationship (Professional Services) with Sanofi;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Professional Services) with Bayer;.

Marwan Fakih, M.D. / Professor

has a financial relationship (Independent contractor) with Roche/Genentech;.
has a financial relationship (Independent contractor) with Bristol Myers Squibb;.
has a financial relationship (Independent contractor) with Nouscom;.
has a financial relationship (Grant Or Contract) with Genentech;.
has a financial relationship (Independent contractor) with Bayer;.
has a financial relationship (Independent contractor) with Mirati Therapeutics;.
has a financial relationship (Grant Or Contract) with AgenusBio;.
has a financial relationship (Independent contractor) with AstraZeneca;.
has a financial relationship (Independent contractor) with Taiho Oncology;.
has a financial relationship (Independent contractor) with Incyte Corporation;.

Xuan Ge, MD, PhD

has no relevant financial relationships to disclose at this time.

Kathryn Gold

has a financial relationship (Independent contractor) with Regeneron;.
has a financial relationship (Independent contractor) with AstraZeneca;.

Syma Iqbal, M.D., F.A.C.P.

has a financial relationship (Professional Services) with BMS;.
has a financial relationship (Professional Services) with Merck;.
has a financial relationship (Professional Services) with Astellas;.
has a financial relationship (Professional Services) with Astra Zeneca;.
has a financial relationship (Professional Services) with Daiichi Sanyko;.

Andy Jang, Assistant Professor of Medicine

has no relevant financial relationships to disclose at this time.

Autumn Jeong, MD

has no relevant financial relationships to disclose at this time.

Sayeh Lavasani, MD, MSc, FRCPC - Breast Oncologist, Associate Professor at UCI

has a financial relationship (Other) with Seagen;.

James Mangan, Associate Clinical Professor of Medicine

has a financial relationship (Professional Services) with Pfizer;.
has a financial relationship (Professional Services) with Adicet Bio;.
has a financial relationship (Professional Services) with Astellas Bio;.
has a financial relationship (Professional Services) with Kura Oncology;.

Rana McKay, MD

has a financial relationship (Other) with Merck;.
has a financial relationship (Other) with Sorrento Therapeutics;.
has a financial relationship (Other) with Bayer;.
has a financial relationship (Other) with Exelixis;.
has a financial relationship (Other) with Myovant;.
has a financial relationship (Other) with SeaGen;.
has a financial relationship (Other) with BMS;.
has a financial relationship (Other) with Dendreon;.
has a financial relationship (Other) with Sanofi;.
has a financial relationship (Other) with Tempus;.
has a financial relationship (Other) with AstraZeneca;.
has a financial relationship (Other) with Caris;.
has a financial relationship (Other) with JNJ;.
has a financial relationship (Other) with Pfizer;.
has a financial relationship (Other) with Telix;.
has a financial relationship (Other) with Aveo;.
has a financial relationship (Other) with Calithera;.
has a financial relationship (Other) with Lilly;.

Soo Park, MD

has a financial relationship (Other) with Regeneron;.

Hardeep Phull, MD

has a financial relationship (Other) with Aveo;.
has a financial relationship (Other) with Mirati;.
has a financial relationship (Other) with Sanofi;.
has a financial relationship (Other) with Karyopharm;.

Jana Portnow, M.D.

has no relevant financial relationships to disclose at this time.

Catherine Quinn, MD

has no relevant financial relationships to disclose at this time.

Aditya Sarvaria, MD

has no relevant financial relationships to disclose at this time.

Abhishek Tripathi, MD

has a financial relationship (Professional Services) with Exelixis;.
has a financial relationship (Professional Services) with Aldi Biosciences;.
has a financial relationship (Grant Or Contract) with Aravive Inc;.
has a financial relationship (Professional Services) with Sanofi ;.
has a financial relationship (Grant Or Contract) with EMD Serono;.
has a financial relationship (Professional Services) with Bayer;.
has a financial relationship (Professional Services) with Deka Biosciences;.
has a financial relationship (Professional Services) with Seattle Genetics;.

Jeffrey Velotta, Jeffrey B. Velotta, MD, FACS

has no relevant financial relationships to disclose at this time.

Victoria Villaflor, M.D.

has a financial relationship (Stock) with Johnson & Johnson;.
has a financial relationship (Professional Services) with AztraZeneca;.
has a financial relationship (Professional Services) with Jazz Phamaceuticals;.
has a financial relationship (Professional Services) with Sanofi;.
has a financial relationship (Professional Services) with Bristol Myers Squibb;.
has a financial relationship (Grant Or Contract) with TGen;.
has a financial relationship (Professional Services) with Novocure;.

Dong Xiang, MD

has no relevant financial relationships to disclose at this time.

Kay Yeung, MD PhD

has a financial relationship (Grant Or Contract) with Dantari;.
has a financial relationship (Grant Or Contract) with Jazz Pharmaceutical;.
has a financial relationship (Grant Or Contract) with Biofluidica;.
has a financial relationship (Grant Or Contract) with Seagen;.
has a financial relationship (Grant Or Contract) with Arvinas;.
has a financial relationship (Grant Or Contract) with Regeneron;.
has a financial relationship (Grant Or Contract) with Gilead;.

Janet Yoon, MD

has a financial relationship (Professional Services) with Sanofi ;.

Yuan Yuan, MD PhD

has a financial relationship (Other) with Merck;.
has a financial relationship (Other) with Gilead;.
has a financial relationship (Other) with Astra Zeneca;.
has a financial relationship (Other) with Diiachi-Sankyo;.
Planning committee(s)

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.

COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported with an independent medical education grant from the following companies:

  • Seagen
  • AstraZeneca

Available Credit

  • 11.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 11.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 11.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 11.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 11.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 11.00 Contact Hours.

 

 

Price

Cost:
$350.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.